← Back to Sun Pharmaceutical Industries Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
SUNPHARMAPharmaceuticals

Sun Pharmaceutical Industries Ltd — Profit & Loss Statement

₹1757.20
+0.66%

Sun Pharmaceutical Industries Ltd Profit & Loss Statement (Annual)

Metric2025202420232022
Tax Effect Of Unusual Items-33.66 Cr-53.38 Cr-16.35 Cr-1.10K Cr
Tax Rate For Calcs0.200.130.090.24
Normalized EBITDA16.73K Cr14.29K Cr12.29K Cr11.32K Cr
Total Unusual Items-166.61 Cr-410.65 Cr-181.45 Cr-4.57K Cr
Total Unusual Items Excluding Goodwill-166.61 Cr-410.65 Cr-181.45 Cr-4.57K Cr
Net Income From Continuing Operation Net Minority Interest10.93K Cr9.58K Cr8.47K Cr3.27K Cr
Reconciled Depreciation2.58K Cr2.56K Cr2.53K Cr2.14K Cr
Reconciled Cost Of Revenue12.20K Cr12.07K Cr11.94K Cr10.35K Cr
EBITDA16.56K Cr13.88K Cr12.11K Cr6.75K Cr
EBIT13.98K Cr11.33K Cr9.58K Cr4.61K Cr
Net Interest Income998.77 Cr784.44 Cr212.54 Cr-127.35 Cr
Interest Expense231.36 Cr238.47 Cr172.00 Cr127.35 Cr
Interest Income1.23K Cr1.02K Cr384.54 Cr553.37 Cr
Normalized Income11.06K Cr9.93K Cr8.64K Cr6.74K Cr
Net Income From Continuing And Discontinued Operation10.93K Cr9.58K Cr8.47K Cr3.27K Cr
Total Expenses39.46K Cr37.29K Cr34.00K Cr30.33K Cr
Rent Expense Supplemental77.74 Cr73.43 Cr58.87 Cr53.54 Cr
Diluted Average Shares239.93 Cr239.93 Cr239.93 Cr240.64 Cr
Basic Average Shares239.93 Cr239.93 Cr239.93 Cr240.64 Cr
Diluted EPS45.6039.9035.3013.60
Basic EPS45.6039.9035.3013.60
Diluted NI Availto Com Stockholders10.93K Cr9.58K Cr8.47K Cr3.27K Cr
Net Income Common Stockholders10.93K Cr9.58K Cr8.47K Cr3.27K Cr
Otherunder Preferred Stock Dividend0.000.000.000.00
Net Income10.93K Cr9.58K Cr8.47K Cr3.27K Cr
Minority Interests-35.71 Cr-33.65 Cr-39.36 Cr-116.55 Cr
Net Income Including Noncontrolling Interests10.96K Cr9.61K Cr8.51K Cr3.39K Cr
Net Income Continuous Operations10.96K Cr9.61K Cr8.51K Cr3.39K Cr
Tax Provision2.77K Cr1.44K Cr847.59 Cr1.08K Cr
Pretax Income13.75K Cr11.09K Cr9.41K Cr4.48K Cr
Other Non Operating Income Expenses86.34 Cr106.49 Cr79.63 Cr921.51 Cr
Special Income Charges-713.34 Cr-502.84 Cr-180.83 Cr-4.57K Cr
Other Special Charges309.53 Cr272.63 Cr-20.87 Cr4.52K Cr
Write Off295.30 Cr0.00164.43 Cr—
Impairment Of Capital Assets7.13 Cr156.26 Cr30.25 Cr20.46 Cr
Restructuring And Mergern Acquisition101.38 Cr73.95 Cr7.02 Cr—
Net Non Operating Interest Income Expense998.77 Cr784.44 Cr212.54 Cr-127.35 Cr
Interest Expense Non Operating231.36 Cr238.47 Cr172.00 Cr127.35 Cr
Interest Income Non Operating1.23K Cr1.02K Cr384.54 Cr553.37 Cr
Operating Income12.58K Cr10.47K Cr9.28K Cr8.10K Cr
Operating Expense27.26K Cr25.22K Cr22.06K Cr19.97K Cr
Other Operating Expenses4.87K Cr4.68K Cr3.74K Cr10.76K Cr
Depreciation And Amortization In Income Statement2.58K Cr2.56K Cr2.53K Cr2.14K Cr
Amortization1.23K Cr1.18K Cr——
Depreciation Income Statement1.35K Cr1.38K Cr2.53K Cr2.14K Cr
Selling General And Administration10.30K Cr9.22K Cr8.04K Cr5.47K Cr
Selling And Marketing Expense6.58K Cr5.78K Cr5.23K Cr3.28K Cr
General And Administrative Expense3.72K Cr3.44K Cr2.82K Cr2.19K Cr
Rent And Landing Fees77.74 Cr73.43 Cr58.87 Cr53.54 Cr
Gross Profit39.84K Cr35.69K Cr31.34K Cr28.07K Cr
Cost Of Revenue12.20K Cr12.07K Cr11.94K Cr10.35K Cr
Total Revenue52.04K Cr47.76K Cr43.28K Cr38.43K Cr
Operating Revenue52.04K Cr47.76K Cr43.28K Cr38.43K Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

More on Sun Pharmaceutical Industries Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.